Poly-Vent IR

Guaifenesin and Pseudoephedrine HCl · Tablet · Oral

Over the counter Expectorant alpha-Adrenergic Agonist

Active ingredient

Active ingredients (in each tablet) Guaifenesin 380mg Pseudoephedrine HCl 60 mg

Purpose

Purpose Expectorant Nasal Decongestant

Uses

Uses Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: helps loosen phlegm and thin bronchial secretions to make coughs more productive nasal congestion runny nose sneezing itching of the nose and throat itchy, watery eyes

Warnings

Warnings Do not exceed recommended dosage. a persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a doctor. Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or if cough is accompanied by excessive phlegm heart disease high blood pressure thyroid disease diabetes difficulty in urination due to enlargement of the prostate gland Stop use and ask a doctor if: nervousness, dizziness, or sleeplessness occur If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use

Ask a doctor before use if you have a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or if cough is accompanied by excessive phlegm heart disease high blood pressure thyroid disease diabetes difficulty in urination due to enlargement of the prostate gland

Stop use and ask a doctor

Stop use and ask a doctor if: nervousness, dizziness, or sleeplessness occur

Pregnancy or breast-feeding

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Directions Adults and children 12 years of age and over: 1 tablet every 4 hours, not to exceed 4 tablets in 24 hours, or as directed by a doctor. Children age 6 to under 12 years of age: ½ tablet every 4 hours, not to exceed 2 tablets in 24 hours, or as directed by a doctor. Children 2 to under 6 years of age: Consult a doctor.

Inactive ingredients

Inactive ingredients FD&C Blue #2, Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate.

Label text from the FDA structured product label by Poly Pharmaceuticals, Inc. (revised Nov 9, 2024). Long sections are shortened; the complete label is on DailyMed.

Active ingredients

Poly-Vent IR NDC products (1)

NDCStrength & formLabelerType
50991-212Guaifenesin 380 mg/1; Pseudoephedrine Hydrochloride 60 mg/1
Tablet
Poly Pharmaceuticals, Inc.OTC MONOGRAPH DRUG

Frequently asked questions

What is Poly-Vent IR used for?

Uses Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: helps loosen phlegm and thin bronchial secretions to make coughs more productive nasal congestion runny nose sneezing itching of the nose and throat itchy, watery eyes

Who makes Poly-Vent IR?

Poly-Vent IR is listed by 1 labeler in the FDA NDC directory, including Poly Pharmaceuticals, Inc..